UBS Lowers Price Target for Scotts Miracle Gro to $68 Amid Neutral Rating
PorAinvest
jueves, 31 de julio de 2025, 5:29 pm ET1 min de lectura
JFU--
The latest move by UBS comes on the heels of several recent analyst ratings and price target adjustments for SMG. In July 2025, Truist Securities maintained a "Buy" rating and raised the price target from $75.00 to $80.00, a 6.67% increase [2]. Wells Fargo also maintained an "Overweight" rating and raised the price target from $72.00 to $75.00, a 4.17% increase [2].
Based on the one-year price targets offered by six analysts, the average target price for SMG is $76.33, with a high estimate of $82.00 and a low estimate of $71.00. This average target implies an upside of 24.63% from the current price of $61.25 [1]. The average brokerage recommendation from 10 firms is 2.2, indicating an "Outperform" status [1].
GuruFocus estimates the GF Value for SMG in one year to be $59.83, suggesting a downside of 2.32% from the current price of $61.25 [1]. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at, calculated based on historical multiples and future performance estimates.
References:
[1] https://www.gurufocus.com/news/3022956/ubs-maintains-neutral-rating-on-smg-but-lowers-price-target-to-68-smg-stock-news
[2] https://www.marketscreener.com/news/scotts-miracle-gro-earnings-call-transcript-smg-usq-transcript-2025-07-30-ce7c5fddd189f62d
SMG--
WFC--
UBS analyst Peter Grom maintains a "Neutral" rating for Scotts Miracle Gro (SMG) but lowers the price target from $71 to $68, a 4.23% decrease. This reflects a cautious stance on the stock amid current market conditions. The average one-year price target from six analysts is $76.33, with an upside of 24.63% from the current price of $61.25. The average brokerage recommendation is 2.2, indicating "Outperform" status. The estimated GF Value in one year is $59.83, suggesting a downside of 2.32% from the current price.
UBS analyst Peter Grom has maintained a "Neutral" rating for Scotts Miracle-Gro (SMG), while lowering the price target from $71.00 to $68.00. This adjustment represents a 4.23% decrease from the previous target, reflecting a cautious stance on the stock amid current market conditions [1].The latest move by UBS comes on the heels of several recent analyst ratings and price target adjustments for SMG. In July 2025, Truist Securities maintained a "Buy" rating and raised the price target from $75.00 to $80.00, a 6.67% increase [2]. Wells Fargo also maintained an "Overweight" rating and raised the price target from $72.00 to $75.00, a 4.17% increase [2].
Based on the one-year price targets offered by six analysts, the average target price for SMG is $76.33, with a high estimate of $82.00 and a low estimate of $71.00. This average target implies an upside of 24.63% from the current price of $61.25 [1]. The average brokerage recommendation from 10 firms is 2.2, indicating an "Outperform" status [1].
GuruFocus estimates the GF Value for SMG in one year to be $59.83, suggesting a downside of 2.32% from the current price of $61.25 [1]. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at, calculated based on historical multiples and future performance estimates.
References:
[1] https://www.gurufocus.com/news/3022956/ubs-maintains-neutral-rating-on-smg-but-lowers-price-target-to-68-smg-stock-news
[2] https://www.marketscreener.com/news/scotts-miracle-gro-earnings-call-transcript-smg-usq-transcript-2025-07-30-ce7c5fddd189f62d

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios